Dorlan Kimbrough

2.5k total citations
21 papers, 517 citations indexed

About

Dorlan Kimbrough is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Dorlan Kimbrough has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 7 papers in Neurology and 6 papers in Rheumatology. Recurrent topics in Dorlan Kimbrough's work include Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (7 papers) and Systemic Lupus Erythematosus Research (4 papers). Dorlan Kimbrough is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (7 papers) and Systemic Lupus Erythematosus Research (4 papers). Dorlan Kimbrough collaborates with scholars based in United States, United Kingdom and Canada. Dorlan Kimbrough's co-authors include Michael Levy, Emmanuelle Waubant, Romain Marignier, Sílvia Tenembaum, Kazuo Fujihara, J. de Sèze, Dean M. Wingerchuk, Anthony Traboulsee, Anu Jacob and Marco Aurélio Lana–Peixoto and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Dorlan Kimbrough

21 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorlan Kimbrough United States 12 344 232 115 80 53 21 517
Anna Maria Repice Italy 11 348 1.0× 207 0.9× 104 0.9× 67 0.8× 19 0.4× 23 495
O. Heinzlef France 10 311 0.9× 235 1.0× 139 1.2× 52 0.7× 21 0.4× 18 531
H.-F. Petereit Germany 14 372 1.1× 190 0.8× 121 1.1× 136 1.7× 17 0.3× 29 594
Susana Otero‐Romero Spain 11 561 1.6× 284 1.2× 189 1.6× 40 0.5× 121 2.3× 26 723
Sara Salama Egypt 10 446 1.3× 473 2.0× 166 1.4× 25 0.3× 74 1.4× 22 637
Harold Moses United States 12 145 0.4× 176 0.8× 53 0.5× 39 0.5× 31 0.6× 19 492
Olwen C. Murphy United States 15 334 1.0× 227 1.0× 163 1.4× 21 0.3× 216 4.1× 47 656
Ana‐Luiza Sayao Canada 11 313 0.9× 98 0.4× 61 0.5× 120 1.5× 35 0.7× 19 455
Sasitorn Siritho Thailand 15 629 1.8× 489 2.1× 231 2.0× 77 1.0× 89 1.7× 54 714
Brent Hayek United States 10 497 1.4× 222 1.0× 65 0.6× 25 0.3× 239 4.5× 27 787

Countries citing papers authored by Dorlan Kimbrough

Since Specialization
Citations

This map shows the geographic impact of Dorlan Kimbrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorlan Kimbrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorlan Kimbrough more than expected).

Fields of papers citing papers by Dorlan Kimbrough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorlan Kimbrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorlan Kimbrough. The network helps show where Dorlan Kimbrough may publish in the future.

Co-authorship network of co-authors of Dorlan Kimbrough

This figure shows the co-authorship network connecting the top 25 collaborators of Dorlan Kimbrough. A scholar is included among the top collaborators of Dorlan Kimbrough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorlan Kimbrough. Dorlan Kimbrough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amezcua, Lilyana, Dalia Rotstein, Afsaneh Shirani, et al.. (2024). Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia. The Lancet Neurology. 23(10). 1050–1062. 5 indexed citations
2.
Kimbrough, Dorlan, et al.. (2022). Neuromyelitis optica: Clinical course and potential prognostic indicators. Multiple Sclerosis and Related Disorders. 69. 104414–104414. 5 indexed citations
3.
Lutz, Michael W., et al.. (2022). Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center. Journal of Neuroimmunology. 373. 577987–577987. 6 indexed citations
4.
Kimbrough, Dorlan, et al.. (2020). A possible case of serum sickness after ocrelizumab infusion. Multiple Sclerosis Journal. 27(1). 155–158. 9 indexed citations
5.
Rosso, Mattia, Dorlan Kimbrough, Cindy Gonzalez, et al.. (2019). Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(1). 2454248368–2454248368. 8 indexed citations
6.
Pawate, Siddharama, Michael Bradshaw, Dorlan Kimbrough, et al.. (2019). Multiple sclerosis and sarcoidosis. Neurology Clinical Practice. 9(3). 218–227. 11 indexed citations
8.
Fitzgerald, Kathryn C., Kicheol Kim, Matthew D. Smith, et al.. (2019). Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain. 142(9). 2722–2736. 33 indexed citations
9.
Khan, Majid, Prakash Ambady, Dorlan Kimbrough, et al.. (2018). Radiation-Induced Myelitis: Initial and Follow-Up MRI and Clinical Features in Patients at a Single Tertiary Care Institution during 20 Years. American Journal of Neuroradiology. 39(8). 1576–1581. 36 indexed citations
10.
Mallery, Robert M., Pieter Poolman, Matthew J. Thurtell, et al.. (2018). Visual Fixation Instability in Multiple Sclerosis Measured Using SLO-OCT. Investigative Ophthalmology & Visual Science. 59(1). 196–196. 13 indexed citations
11.
Sattarnezhad, Neda, et al.. (2017). Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients. Multiple Sclerosis Journal. 24(8). 1126–1130. 5 indexed citations
12.
Kim, Gloria, Renxin Chu, Shahamat Tauhid, et al.. (2017). Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. International Journal of Neuroscience. 127(11). 971–980. 11 indexed citations
13.
Kimbrough, Dorlan & Scott D. Newsome. (2016). Case Report: Two Cases of Nicolau Syndrome Associated with Glatiramer Acetate. International Journal of MS Care. 19(3). 148–150. 9 indexed citations
14.
Kimbrough, Dorlan, Elias S. Sotirchos, James A. Wilson, et al.. (2014). Retinal damage and vision loss in African American multiple sclerosis patients. Annals of Neurology. 77(2). 228–236. 46 indexed citations
15.
Kimbrough, Dorlan, et al.. (2013). Identifying Multiple Sclerosis in Patients with Systemic Sarcoidosis (P06.214). Neurology. 80(7_supplement). 2 indexed citations
16.
Lyons, Jennifer, Karen L. Roos, Kieren A. Marr, et al.. (2013). Cerebrospinal Fluid (1,3)-β- d -Glucan Detection as an Aid for Diagnosis of Iatrogenic Fungal Meningitis. Journal of Clinical Microbiology. 51(4). 1285–1287. 36 indexed citations
17.
Kimbrough, Dorlan, Kazuo Fujihara, Anu Jacob, et al.. (2012). Treatment of neuromyelitis optica: Review and recommendations. Multiple Sclerosis and Related Disorders. 1(4). 180–187. 194 indexed citations
18.
Shuaib, Faisal, et al.. (2010). Factors associated with incomplete childhood immunization among residents in St. Mary, Jamaica.. PubMed. 59(5). 549–54. 12 indexed citations
19.
Graber, Jerome, et al.. (2010). Overlapping and distinct mechanisms of action of multiple sclerosis therapies. Clinical Neurology and Neurosurgery. 112(7). 583–591. 24 indexed citations
20.
Kimbrough, Dorlan, et al.. (2008). Acute Bacterial Parotitis Following Acute Stroke. Infection. 37(3). 283–285. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026